advanced search

Welcome: Guest

log in

0 items in basket Total: £0
$0 / €0

View Basket

Australia Wound Care Management Investment Opportunities, Analysis and Forecasts to 2015

Publication Date June 2009
Publisher Global Markets Direct
Product Type Report
Pages 119
ISBN Number not applicable
Product Code GMD07506
Buy this product or for assistance call +44 20 7060 7474
PDF £1,505.00$2503 | €1684
FAX Order above formats by FAX

Summary

Australia Wound Care Management Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Australia wound care management market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management market in Australia

Scope

  • The report provides wound care management information broken down into detailed categories and segments in Australia.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the wound care management market in Australia.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content

  • 1 Table of Contents
    • 1.1 1.2 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 Wound Care Management
    • 3.2 Advanced Wound Management
      • 3.2.1 Alginates
      • 3.2.2 Collagens
      • 3.2.3 Foams
      • 3.2.4 Hydrocolloids
      • 3.2.5 Hydrofibres
      • 3.2.6 Hydrogels
      • 3.2.7 Negative Pressure Wound Therapy (NPWT)
      • 3.2.8 Semi-Permeable Films
    • 3.3 Compression Therapy
    • 3.4 Ostomy
    • 3.5 Traditional Wound Management
    • 3.6 Wound Closure Devices
      • 3.6.1 Skin Closure Devices
      • 3.6.2 Tissue Sealants
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
      • 5.1.2 Registration and Conformity Assessment
    • 5.2 Advertising
    • 5.3 Labeling and Packaging
    • 5.4 Post-market Surveillance
    • 5.5 Registration Fee
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
  • 8 Wound Care Management In Australia
    • 8.1 Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 Wound Care Management, Australia, Overall Revenue ($ mn), 2000-2015
    • 8.3 Wound Care Management, Australia, Category Volume (Units), 2000-2015
    • 8.4 Wound Care Management, Australia, Company Share (2006-2007)
  • 9 Advanced Wound Management In Australia
    • 9.1 Advanced Wound Management Overall Revenue (2000-2015)
    • 9.2 Advanced Wound Management Overall Volume (2000-2015)
    • 9.3 Advanced Wound Management Average Price (2000-2015)
    • 9.4 Advanced Wound Management Distribution Share (2007-2008)
    • 9.5 Advanced Wound Management, Australia, Company Share (2006-2007)
  • 10 Compression Therapy In Australia
    • 10.1 Compression Therapy Overall Revenue (2000-2015)
    • 10.2 Compression Therapy Overall Volume (2000-2015)
    • 10.3 Compression Therapy Average Price (2000-2015)
    • 10.4 Compression Therapy Distribution Share (2007-2008)
    • 10.5 Compression Therapy, Australia, Company Share (2006-2007)
  • 11 Ostomy In Australia
    • 11.1 Ostomy Overall Revenue (2000-2015)
    • 11.2 Ostomy Overall Volume (2000-2015)
    • 11.3 Ostomy Average Price (2000-2015)
    • 11.4 Ostomy Distribution Share (2007-2008)
    • 11.5 Ostomy, Australia, Company Share (2006-2007)
  • 12 Traditional Wound Management In Australia
    • 12.1 Traditional Wound Management Overall Revenue (2000-2015)
    • 12.2 Traditional Wound Management Overall Volume (2000-2015)
    • 12.3 Traditional Wound Management Average Price (2000-2015)
    • 12.4 Traditional Wound Management Distribution Share (2007-2008)
    • 12.5 Traditional Wound Management, Australia, Company Share (2006-2007)
  • 13 Wound Closure Devices In Australia
    • 13.1 Wound Closure Devices Overall Revenue (2000-2015)
    • 13.2 Wound Closure Devices Overall Volume (2000-2015)
    • 13.3 Wound Closure Devices Average Price (2000-2015)
    • 13.4 Wound Closure Devices Distribution Share (2007-2008)
    • 13.5 Wound Closure Devices, Australia, Company Share (2006-2007)
  • 14 Overview of Key Companies in Australia Wound Care Management Market
    • 14.1 Smith & Nephew Plc
      • 14.1.1 Company Overview
      • 14.1.2 Value Chain Analysis
        • 14.1.2.1 Manufacturing
        • 14.1.2.2 Product Development
        • 14.1.2.3 Sales and Marketing
      • 14.1.3 Smith & Nephew Plc Pipeline Products
        • 14.1.3.1 Smith & Nephew Plc Pipeline Products By Equipment Type
        • 14.1.3.2 Smith & Nephew Plc Pipeline Products By Development Stage
        • 14.1.3.3 Smith & Nephew Plc Pipeline Products By Therapy Area
        • 14.1.3.4 Smith & Nephew Plc Pipeline Products By News Summary
    • 14.2 HARTMANN GROUP
      • 14.2.1 Company Overview
      • 14.2.2 Value Chain Analysis
        • 14.2.2.1 Manufacturing
        • 14.2.2.2 Product Development
        • 14.2.2.3 Sales and Marketing
    • 14.3 Ethicon, Inc
      • 14.3.1 Company Overview
      • 14.3.2 Ethicon, Inc. Pipeline Products
        • 14.3.2.1 Ethicon, Inc. Pipeline Products By Equipment Type
        • 14.3.2.2 Ethicon, Inc. Pipeline Products By Development Stage
        • 14.3.2.3 Ethicon, Inc. Pipeline Products By Therapy Area
        • 14.3.2.4 Ethicon, Inc. Pipeline Products By Clinical Trials
    • 14.4 Covidien Ltd
      • 14.4.1 Company Overview
      • 14.4.2 Value Chain Analysis
        • 14.4.2.1 Manufacturing
        • 14.4.2.2 Product Development
        • 14.4.2.3 Sales and Marketing
    • 14.5 ConvaTec
      • 14.5.1 Company Overview
    • 14.6 Coloplast A/S
      • 14.6.1 Company Overview
      • 14.6.2 Value Chain Analysis
        • 14.6.2.1 Manufacturing
        • 14.6.2.2 Product Development
        • 14.6.2.3 Sales and Marketing
    • 14.7 Baxter International Inc
      • 14.7.1 Company Overview
      • 14.7.2 Value Chain Analysis
        • 14.7.2.1 Manufacturing
        • 14.7.2.2 Product Development
        • 14.7.2.3 Sales and Marketing
    • 14.8 Hollister Incorporated
      • 14.8.1 Company Overview
    • 14.9 Molnlycke Health Care AB
      • 14.9.1 Company Overview
    • 14.10 BSN medical GmbH
      • 14.10.1 Company Overview
    • 14.11 Johnson & Johnson
      • 14.11.1 Company Overview
      • 14.11.2 Value Chain Analysis
        • 14.11.2.1 Manufacturing
        • 14.11.2.2 Product Development
        • 14.11.2.3 Sales and Marketing
    • 14.12 Unomedical Pty Ltd
      • 14.12.1 Company Overview
    • 14.13 Avita Medical Ltd
      • 14.13.1 Company Overview
      • 14.13.2 Avita Medical Ltd Pipeline Products
        • 14.13.2.1 Avita Medical Ltd Pipeline Products By Equipment Type
        • 14.13.2.2 Avita Medical Ltd Pipeline Products By Development Stage
        • 14.13.2.3 Avita Medical Ltd Pipeline Products By Therapy Area
        • 14.13.2.4 Avita Medical Ltd Pipeline Products By News Summary
    • 14.14 CollTech Australia Limited
      • 14.14.1 Company Overview
      • 14.14.2 CollTech Australia Limited Pipeline Products
        • 14.14.2.1 CollTech Australia Limited Pipeline Products By Equipment Type
        • 14.14.2.2 CollTech Australia Limited Pipeline Products By Development Stage
  • 15 Financial Deals Landscape
    • 15.1 Partnerships
      • 15.1.1 Angiotech Pharmaceuticals Enters Into An Agreement With Baxter International
  • 16 Appendix
    • 16.1 Global Markets Direct Research Methodology
    • 16.2 Coverage
    • 16.3 Secondary Research
    • 16.4 Primary Research
    • 16.5 Models
    • 16.6 Forecasts
    • 16.7 Expert Panel Validation
    • 16.8 Currency Conversion
    • 16.9 Contact Us
    • 16.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Healthcare Infrastructure in Australia, 2005
    • Table 2: Healthcare Personnel in Australia, 2005
    • Table 3: Hospital Wards by Specialty in Australia, 2003-2007
    • Table 4: Doctors by Specialty in Australia, 2003-2007
    • Table 5: Conformity Assessment of Medical Devices based Device Class, in Australia, 2007
    • Table 6: Fee for Registered Device in Australia, 2007
    • Table 7: Fee for Device Clinical Trial in Australia, 2007
    • Table 8: Evaluation Fee for High and Low Level Registration of Medical Device in Australia, 2007
    • Table 9: Evaluation Fee for Variation Registration of Medical Device in Australia, 2007
    • Table 10: Fee for Registration of Listed Devices in Australia, 2007
    • Table 11: Fee for Registration of Listed Devices for Export Only in Australia, 2007
    • Table 12: Fee for Registration of Included Devices in Australia, 2007
    • Table 13: Fee for Initial Conformity Assessment of Medical Device in Australia, 2007
    • Table 14: Fee for Medical Device Changes Conformity Assessment in Australia, 2007
    • Table 15: Fee for Medical Device Conformity Assessment Surveillance Audit in Australia, 2007
    • Table 16: Fee for Medical Device Conformity Assessment Review Certificate in Australia, 2007
    • Table 17: Fee for Initial Conformity Assessment of Medical Device Components in Australia, 2007
    • Table 18: Fee for Conformity Assessment of Changes in Medical Device Components in Australia, 2007
    • Table 19: Fee for Abridged Conformity Assessment of Medical Device Components in Australia, 2007
    • Table 20: Fee for Inclusion of Medical Device in the Register in Australia, 2007
    • Table 21: Fee for ARTG Inclusion for Medical Device in Australia, 2007
    • Table 22: Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 23: Wound Care Management, Australia, Overall Revenue ($ mn), 2000-2015
    • Table 24: Wound Care Management, Australia, Cross-Category Analysis, 2000-2015
    • Table 25: Wound Care Management, Australia, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 26: Wound Care Management, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 27: Wound Care Management, Australia, Category Volume (Units), 2000-2015
    • Table 28: Wound Care Management, Australia, Category Volume (Units), Historic, 2000-2008
    • Table 29: Wound Care Management, Australia, Category Volume (Units), Forecast, 2008-2015
    • Table 30: Wound Care Management, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 31: Advanced Wound Management, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 32: Advanced Wound Management, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 33: Advanced Wound Management, Australia, Volume (Units) by Segment, Historic, 2000-2008
    • Table 34: Advanced Wound Management, Australia, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 35: Advanced Wound Management, Australia, Average Price ($), Historic, 2000-2008
    • Table 36: Advanced Wound Management, Australia, Average Price ($), Forecast, 2008-2015
    • Table 37: Advanced Wound Management, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 38: Advanced Wound Management, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 39: Compression Therapy, Australia, Revenue ($ mn), Historic, 2000-2008
    • Table 40: Compression Therapy, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Table 41: Compression Therapy, Australia, Volume (Units), Historic, 2000-2008
    • Table 42: Compression Therapy, Australia, Volume (Units), Forecast, 2008-2015
    • Table 43: Compression Therapy, Australia, Average Price ($), Historic, 2000-2008
    • Table 44: Compression Therapy, Australia, Average Price ($), Forecast, 2008-2015
    • Table 45: Compression Therapy, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 46: Compression Therapy, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 47: Ostomy, Australia, Revenue ($ mn), Historic, 2000-2008
    • Table 48: Ostomy, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Table 49: Ostomy, Australia, Volume (Units), Historic, 2000-2008
    • Table 50: Ostomy, Australia, Volume (Units), Forecast, 2008-2015
    • Table 51: Ostomy, Australia, Average Price ($), Historic, 2000-2008
    • Table 52: Ostomy, Australia, Average Price ($), Forecast, 2008-2015
    • Table 53: Ostomy, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 54: Ostomy, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 55: Traditional Wound Management, Australia, Revenue ($ mn), Historic, 2000-2008
    • Table 56: Traditional Wound Management, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Table 57: Traditional Wound Management, Australia, Volume (Units), Historic, 2000-2008
    • Table 58: Traditional Wound Management, Australia, Volume (Units), Forecast, 2008-2015
    • Table 59: Traditional Wound Management, Australia, Average Price ($), Historic, 2000-2008
    • Table 60: Traditional Wound Management, Australia, Average Price ($), Forecast, 2008-2015
    • Table 61: Traditional Wound Management, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 62: Traditional Wound Management, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 63: Wound Closure Devices, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 64: Wound Closure Devices, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 65: Wound Closure Devices, Australia, Volume (Units) by Segment, Historic, 2000-2008
    • Table 66: Wound Closure Devices, Australia, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 67: Wound Closure Devices, Australia, Average Price ($), Historic, 2000-2008
    • Table 68: Wound Closure Devices, Australia, Average Price ($), Forecast, 2008-2015
    • Table 69: Wound Closure Devices, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 70: Wound Closure Devices, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 71: Smith & Nephew Plc Pipeline Products by Equipment Type
    • Table 72: Smith & Nephew Plc Pipeline Products By Development Stage
    • Table 73: Smith & Nephew Plc Pipeline Products By Therapy Area
    • Table 74: Smith & Nephew Plc Pipeline Products By News Summary
    • Table 75: Ethicon, Inc. Pipeline Products by Equipment Type
    • Table 76: Ethicon, Inc. Pipeline Products By Development Stage
    • Table 77: Ethicon, Inc. Pipeline Products By Therapy Area
    • Table 78: Ethicon, Inc. Pipeline Products By Clinical Trials
    • Table 79: Avita Medical Ltd Pipeline Products by Equipment Type
    • Table 80: Avita Medical Ltd Pipeline Products By Development Stage
    • Table 81: Avita Medical Ltd Pipeline Products By Therapy Area
    • Table 82: Avita Medical Ltd Pipeline Products By News Summary
    • Table 83: CollTech Australia Limited Pipeline Products by Equipment Type
    • Table 84: CollTech Australia Limited Pipeline Products By Development Stage
    • Table 85: Angiotech Pharmaceuticals Enters Into An Agreement With Baxter International
    • Table 86: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in Australia, 2000 - 2005
    • Figure 2: Healthcare Financing Framework in Australia, 2007
    • Figure 3: Healthcare System in Australia, 2007
    • Figure 4: Classification of Medical Devices in Australia, 2007
    • Figure 5: Classification of Noninvasive Devices in Australia, 2007
    • Figure 6: Classification of Invasive Devices in Australia, 2007
    • Figure 7: Classification of Invasive Devices in Australia, 2007
    • Figure 8: Classification of Active Devices in Australia, 2007
    • Figure 9: Classification of Special Medical Devices in Australia, 2007
    • Figure 10: Conformity Assessment Procedure for Medical Devices in Australia, 2007
    • Figure 11: Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 12: Wound Care Management, Australia, Overall Revenue ($ mn), 2000-2015
    • Figure 13: Wound Care Management, Australia, Cross-Category Analysis, 2000-2015
    • Figure 14: Wound Care Management, Australia, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 15: Wound Care Management, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 16: Wound Care Management, Australia, Category Volume (Units), 2000-2015
    • Figure 17: Wound Care Management, Australia, Category Volume (Units), Historic, 2000-2008
    • Figure 18: Wound Care Management, Australia, Category Volume (Units), Forecast, 2008-2015
    • Figure 19: Wound Care Management, Australia, Company Share (%), 2007
    • Figure 20: Advanced Wound Management, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 21: Advanced Wound Management, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 22: Advanced Wound Management, Australia, Company Share (%), 2007
    • Figure 23: Compression Therapy, Australia, Revenue ($ mn), Historic, 2000-2008
    • Figure 24: Compression Therapy, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Figure 25: Compression Therapy, Australia, Volume (Units), Historic, 2000-2008
    • Figure 26: Compression Therapy, Australia, Volume (Units), Forecast, 2008-2015
    • Figure 27: Compression Therapy, Australia, Company Share (%), 2007
    • Figure 28: Ostomy, Australia, Revenue ($ mn), Historic, 2000-2008
    • Figure 29: Ostomy, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Figure 30: Ostomy, Australia, Volume (Units), Historic, 2000-2008
    • Figure 31: Ostomy, Australia, Volume (Units), Forecast, 2008-2015
    • Figure 32: Ostomy, Australia, Company Share (%), 2007
    • Figure 33: Traditional Wound Management, Australia, Revenue ($ mn), Historic, 2000-2008
    • Figure 34: Traditional Wound Management, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Figure 35: Traditional Wound Management, Australia, Volume (Units), Historic, 2000-2008
    • Figure 36: Traditional Wound Management, Australia, Volume (Units), Forecast, 2008-2015
    • Figure 37: Traditional Wound Management, Australia, Company Share (%), 2007
    • Figure 38: Wound Closure Devices, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 39: Wound Closure Devices, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 40: Wound Closure Devices, Australia, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 41: Wound Closure Devices, Australia, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 42: Wound Closure Devices, Australia, Company Share (%), 2007
    • Figure 43: Smith & Nephew Plc Value Chain Analysis
    • Figure 44: Hartmann Group Value Chain Analysis
    • Figure 45: Covidien Ltd./Tyco Healthcare Value Chain Analysis
    • Figure 46: Coloplast A/S Value Chain Analysis
    • Figure 47: Baxter International Inc. Value Chain Analysis
    • Figure 48: Johnson & Johnson Value Chain Analysis
    • Figure 49: Global Markets Direct Methodology

back to top

Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

Ask a question about this product

Need help finding the right product?

Product features / use
Scope Expert Insight/Opinion yes
Profiles In-depth Company Insight yes
Features Primary Research Data yes
Related Products

Industry Events

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>

Pharma & Healthcare

Customer Services

How To Buy
Formats & Delivery
Terms & Conditions
Account Options
Login/Register

call +44 (0) 20 7060 7474
or email us

Resources

Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories

Post it

Del.icio.us
StumbleUpon
Reddit

logo: AddThis